Medisystem provides a high-level automated disinfection system with “no touch” technology, together with evidence-based decontamination protocols, mainly in critical areas and on the main multidrug-resistant pathogens, even in areas that are difficult to reach. Medisystem combines automated dispensing devices with disinfectant chemicals, both developed by the company.
The AMIL Care range of micronebulizers includes devices that can treat maximum volumes ranging from 500 cubic metres to 10,000, with a number of nozzles varying from one to four. The device is protected by a patent, which guarantees a standardised protocol regardless of human intervention. Thanks to a fine calibration, the system disinfects by saturating a confined space, delivering the product in a constant quantity and at a constant rate, according to the assigned protocol. Standardisation and automation of the process allow greater safety and exclude the possibility of human error.